- Home
- AGEN vs MDIA Comparison
AGEN vs MDIA Comparison
Compare AGEN & MDIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGEN
- MDIA
- Stock Information
- Founded
- AGEN 1994
- MDIA 2019
- Country
- AGEN United States
- MDIA United States
- Employees
- AGEN N/A
- MDIA N/A
- Industry
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- MDIA Broadcasting
- Sector
- AGEN Health Care
- MDIA Consumer Discretionary
- Exchange
- AGEN Nasdaq
- MDIA Nasdaq
- Market Cap
- AGEN 126.8M
- MDIA 102.4M
- IPO Year
- AGEN 2000
- MDIA N/A
- Fundamental
- Price
- AGEN $4.29
- MDIA $0.95
- Analyst Decision
- AGEN Buy
- MDIA
- Analyst Count
- AGEN 2
- MDIA 0
- Target Price
- AGEN $14.50
- MDIA N/A
- AVG Volume (30 Days)
- AGEN 460.1K
- MDIA 33.6K
- Earning Date
- AGEN 11-10-2025
- MDIA 11-19-2025
- Dividend Yield
- AGEN N/A
- MDIA N/A
- EPS Growth
- AGEN N/A
- MDIA N/A
- EPS
- AGEN N/A
- MDIA N/A
- Revenue
- AGEN $106,829,000.00
- MDIA $127,477,000.00
- Revenue This Year
- AGEN $60.49
- MDIA N/A
- Revenue Next Year
- AGEN N/A
- MDIA N/A
- P/E Ratio
- AGEN N/A
- MDIA N/A
- Revenue Growth
- AGEN N/A
- MDIA 83.96
- 52 Week Low
- AGEN $1.38
- MDIA $0.79
- 52 Week High
- AGEN $7.34
- MDIA $1.90
- Technical
- Relative Strength Index (RSI)
- AGEN 54.02
- MDIA 31.84
- Support Level
- AGEN $4.17
- MDIA $0.92
- Resistance Level
- AGEN $4.60
- MDIA $1.12
- Average True Range (ATR)
- AGEN 0.28
- MDIA 0.05
- MACD
- AGEN 0.04
- MDIA 0.00
- Stochastic Oscillator
- AGEN 61.32
- MDIA 14.09
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
About MDIA Mediaco Holding Inc.
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming, and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales, events including sponsorships and ticket sales, licensing, and syndication. The company has two business segments: the Audio segment and the Video segment. The company generates the majority of its revenue from the Audio segment.